Back to search

University of Washington

Estimators of Effect Modification of Cumulative Incidence: Aalen-Johansen and Targeted Minimum Loss-based Estimator

Abstract

dc:description.abstract

In time to event settings there are many occasions in which multiple events can occur. This competing risks phenomenon is often encountered in vaccine trials when interest is given to efficacy against a specific subtype of the disease, particularly those included (or not) in the formulation of the vaccine. In these settings, the parameter of interest is cumulative incidence - the probability of being infected by a particular subtype by a certain time. In this thesis we present and compare two estimators of cumulative incidence in various simulated scenarios and compare additive and multiplicative treatment effects as well as effect modification across groups. We apply these estimators to two phase-III double-blind placebo controlled trials of Sanofi Pasteur's dengue vaccine, which has recently been approved in Mexico and is likely to gain approval from the FDA and many other countries in 2016.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fernandez Oromendia, Maria Clara
Advisor dc:contributor.advisor
  • Carone, Marco

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/35137

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Fernandez Oromendia, Maria Clara. Estimators of Effect Modification of Cumulative Incidence: Aalen-Johansen and Targeted Minimum Loss-based Estimator. 2016. http://hdl.handle.net/1773/35137